|  | | | | | | | | | What you need to know about the coronavirus today | | | | | | UK testing in chaos
Amid growing anger over a bottleneck in Britain’s creaking coronavirus testing system, the government promised to do whatever it takes to boost laboratory capacity that has left people across the land with no way to get a COVID-19 test.
In an attempt to slow one of the highest coronavirus death tolls in the West, Prime Minister Boris Johnson promised in May to create a “world-beating” system to test and trace people exposed to the virus.
But repeated attempts by Reuters reporters to get COVID-19 tests failed, while at a walk-in testing center at Southend-on-Sea in eastern England hundreds of people were queuing to get a test - some from as early as 0500 GMT.
Russia to sell 100 million doses of vaccine to India
Russia’s sovereign wealth fund has agreed to supply 100 million doses of its coronavirus vaccine, Sputnik-V, to Indian drug company Dr Reddy’s Laboratories, as Moscow speeds up plans to distribute its shot abroad.
The deal comes after the Russian Direct Investment Fund (RDIF) reached agreements with Indian manufacturers to produce 300 million doses of the vaccine in India, which is a major consumer of Russian oil and arms.
Dr Reddy’s, one of India’s top pharmaceutical companies, will carry out Phase III clinical trials of the vaccine in India, pending regulatory approval, RDIF said in a statement. Deliveries to India could begin in late 2020.
The agreement comes as India’s coronavirus cases surged past 5 million.
China inoculates before vaccine trials completed
China is inoculating tens of thousands of its citizens with experimental coronavirus vaccines and attracting international interest in their development, despite concerns among experts over the safety of drugs that have not completed standard testing.
Aiming to protect essential workers and reduce the likelihood of a resurgence of the pandemic, the vaccines are also grabbing attention in the global scramble by governments to secure supplies.
China’s approach runs counter to that of many Western countries, where experts have warned against authorizing the emergency use of vaccines that have not completed testing, citing a lack of understanding about longer-term efficacy and potential side effects.
Australia on track to relax extended hard lockdown
Australia’s Victoria state on Wednesday said the daily rise in infections in its coronavirus hot spot of Melbourne has eased further, putting it on course to relax an extended hard lockdown in the city by the end of the month.
Construction sites, manufacturing plants, warehouses and childcare facilities can reopen, allowing more than 100,000 workers to return to their jobs, if the 14-day rolling average is under 50 cases as of Sept. 28.
From late Wednesday, in regional Victoria, outdoor gatherings of up to 10 people will be permitted, residents of a household will be allowed to visit one other home, and cafes will be able to seat up to 50 people outdoors.
Track the spread with our global and U.S.-focused live graphics. | | | | | | | | | | | | Reuters reporters and editors around the world are investigating the response to the coronavirus pandemic.
We need your help to tell these stories. Our news organization wants to capture the full scope of what’s happening and how we got here by drawing on a wide variety of sources.
Are you a government employee or contractor involved in coronavirus testing or the wider public health response? Are you a doctor, nurse or health worker caring for patients? Have you worked on similar outbreaks in the past? Has the disease known as COVID-19 personally affected you or your family? Are you aware of new problems that are about to emerge, such as critical supply shortages?
We need your tips, firsthand accounts, relevant documents or expert knowledge. Please contact us at coronavirus@reuters.com.
We prefer tips from named sources, but if you’d rather remain anonymous, you can submit a confidential news tip. Here’s how. | | | | | | | | | | | | | | | | | Top Stories on Reuters TV | | | | | | | |
